Infectious Diseases

Infectious Diseases

Pages

Medical News

Will the When-to-Start Discussion Finally End? Free

Results from the START study, released early, support offering ART to all HIV-infected people, regardless of CD4-cell count.

Drug Watch / Vaccine Watch

FDA Approves Isavuconazonium (Cresemba)

Isavuconazonium is noninferior to voriconazole for invasive aspergillosis and has efficacy for invasive mucormycosis.

HIV and ID Observations Blog

Post-Exposure Prophylaxis for HCV Can’t Be Cost-Effective — But We Might End Up Recommending It Anyway Free

Is post-exposure prophylaxis for hepatitis C virus a no-brainer? Dr. Paul Sax asks this question in HIV and ID Observations.

Guideline Watch

New Sexually Transmitted Diseases Treatment Guidelines Issued by the CDC

Released by the CDC nearly 2 years after consultation with experts in the field, these guidelines update the previous version, issued in 2010.